已收盘 05-08 16:00:00 美东时间
-1.150
-0.88%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
The latest announcement is out from Leidos Holdings ( ($LDOS) ). At its May 1, ...
05-07 05:24
RBC Capital analyst Ken Herbert maintains Leidos Holdings (NYSE:LDOS) with a Outperform and lowers the price target from $215 to $180.
05-06 23:43
Leidos Holdings shares are trading lower. The company reported Q1 financial res...
05-06 02:43
Earnings Call Insights: Leidos Holdings, Inc. (LDOS) Q1 2026 Management View "First quarter revenue was up 4% year-on-year to $4.4 billion, and profitability remained excellent to start 2026, with adj...
05-06 00:44
华盛资讯5月5日讯,Leidos Holdings, Inc.公布2026财年Q2业绩,公司Q2营收44.00亿美元,同比增长3.7%,归母净利润3.28亿美元,同比下滑9.6%。
05-05 23:02
华盛资讯5月5日讯,Leidos Holdings, Inc.公布2026财年Q2业绩,公司Q2营收44.00亿美元,同比增长3.7%,归母净利润3.28亿美元,同比下滑9.6%。
05-05 22:01
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Leidos Holdings (NYSE:LDOS) raises FY2026 Adj EPS guidance from $12.05-$12.45 to $12.10-$12.50 vs $12.29 analyst estimate. Raises FY2026 sales outlook from $17.500 billion-$17.900 billion to $18.000 billion-$18.400
05-05 18:04